These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37698922)

  • 1. Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease.
    Sorokin AV; Hong CG; Aponte AM; Florida EM; Tang J; Patel N; Baranova IN; Li H; Parel PM; Chen V; Wilson SR; Ongstad EL; Collén A; Playford MP; Eggerman TL; Chen MY; Kotani K; Bocharov AV; Remaley AT
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37698922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex association of apolipoprotein E-containing HDL with coronary artery disease burden in cardiovascular disease.
    Sorokin AV; Patel N; Abdelrahman KM; Ling C; Reimund M; Graziano G; Sampson M; Playford MP; Dey AK; Reddy A; Teague HL; Stagliano M; Amar M; Chen MY; Mehta NN; Remaley AT
    JCI Insight; 2022 May; 7(10):. PubMed ID: 35389891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography.
    Suruga K; Miyoshi T; Kotani K; Ichikawa K; Miki T; Osawa K; Ejiri K; Toda H; Nakamura K; Morita H; Ito H
    Int J Cardiol; 2021 Feb; 324():193-198. PubMed ID: 32987049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.
    Sorokin AV; Kotani K; Elnabawi YA; Dey AK; Sajja AP; Yamada S; Ueda M; Harrington CL; Baumer Y; Rodante JA; Gelfand JM; Chen MY; Joshi AA; Playford MP; Remaley AT; Mehta NN
    Circ Res; 2018 Nov; 123(11):1244-1254. PubMed ID: 30571459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between high oxidized high-density lipoprotein levels and increased pericoronary inflammation determined by coronary computed tomography angiography.
    Ichikawa K; Miyoshi T; Kotani K; Osawa K; Nakashima M; Nishihara T; Ito H
    J Cardiol; 2022 Nov; 80(5):410-415. PubMed ID: 35853799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study.
    Sorokin AV; Patel N; Li H; Hong CG; Sampson M; O'Hagan R; Florida EM; Teague HL; Playford MP; Chen MY; Mehta NN; Remaley AT
    Lipids Health Dis; 2023 Apr; 22(1):55. PubMed ID: 37106374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.
    Karpouzas GA; Ormseth SR; Ronda N; Hernandez E; Budoff MJ
    J Autoimmun; 2022 May; 129():102815. PubMed ID: 35366608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein cholesterol, triglycerides, and characteristics of coronary atherosclerosis in patients with significant coronary artery disease newly diagnosed by computed tomography coronary angiography.
    Oleksiak A; Kępka C; Rucińska K; Marcinkiewicz K; Demkow M; Kruk M
    Kardiol Pol; 2023; 81(3):273-280. PubMed ID: 36475513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study.
    Voros S; Joshi P; Qian Z; Rinehart S; Vazquez-Figueroa JG; Anderson H; Elashoff M; Murrieta L; Karmpaliotis D; Kalynych A; Brown C; Schaefer E; Asztalos B
    J Am Heart Assoc; 2013 Nov; 2(6):e000344. PubMed ID: 24252842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration.
    Zhou B; Zu L; Chen Y; Zheng X; Wang Y; Pan B; Dong M; Zhou E; Zhao M; Zhang Y; Zheng L; Gao W
    Lipids Health Dis; 2017 Jan; 16(1):3. PubMed ID: 28069011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers.
    Marin MT; Dasari PS; Tryggestad JB; Aston CE; Teague AM; Short KR
    J Diabetes Complications; 2015 Jul; 29(5):679-85. PubMed ID: 25881918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in oxidized high-density lipoprotein is associated with slowed progression of coronary artery calcification: Subanalysis of a prospective multicenter study.
    Miki T; Miyoshi T; Kotani K; Kohno K; Asonuma H; Sakuragi S; Koyama Y; Nakamura K; Ito H
    Atherosclerosis; 2019 Apr; 283():1-6. PubMed ID: 30769272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
    Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shishido K; Takahashi K; Hosaka N; Ikeda M; Sanada D; Shibata T
    PLoS One; 2017; 12(5):e0177980. PubMed ID: 28542510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
    J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of high-density lipoprotein levels with baseline coronary plaque volumes by coronary CTA in the EVAPORATE trial.
    Lakshmanan S; Shekar C; Kinninger A; Dahal S; Onuegbu A; Cai AN; Hamal S; Birudaraju D; Cherukuri L; Flores F; Dailing C; Roy SK; Bhatt DL; Nelson JR; Budoff MJ
    Atherosclerosis; 2020 Jul; 305():34-41. PubMed ID: 32615321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
    Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.